Non-invasive Diaphragm Stimulation System
Prevention/Treatment of Ventilator-Induced Diaphragm Dysfunction (VIDD) in ICU Patients
Key Facts
About Stimit AG
Stimit AG is a private, pre-revenue medical device innovator targeting a critical unmet need in respiratory and critical care. The company's core technology is a non-invasive system for transcutaneous diaphragm stimulation, aimed at maintaining diaphragm muscle mass and function in sedated, mechanically ventilated ICU patients to reduce ventilator-induced diaphragm dysfunction (VIDD). By promoting a more natural, diaphragm-driven breath, Stimit's approach has the potential to shorten ventilation time, decrease ICU complications, and improve patient outcomes. The technology is currently in development, with no approved products on the market as of the provided information.
View full company profile